CNP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6278089987054E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.5527136788005E-15 |
Normal-vs-Stage2 |
4.44089209850063E-16 |
Normal-vs-Stage3 |
2.99760216648792E-15 |
Normal-vs-Stage4 |
1.64146474190829E-12 |
Stage1-vs-Stage2 |
7.101500E-02 |
Stage1-vs-Stage3 |
7.285800E-01 |
Stage1-vs-Stage4 |
2.029400E-01 |
Stage2-vs-Stage3 |
1.770350E-01 |
Stage2-vs-Stage4 |
2.396100E-02 |
Stage3-vs-Stage4 |
1.797850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62669877568078E-12 |
Normal-vs-AfricanAmerican |
1.6654455592402E-12 |
Normal-vs-Asian |
1.940150E-02 |
Caucasian-vs-AfricanAmerican |
3.020300E-02 |
Caucasian-vs-Asian |
1.414400E-01 |
AfricanAmerican-vs-Asian |
2.468800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62625468647093E-12 |
Normal-vs-Female |
1.63824509513688E-12 |
Male-vs-Female |
7.438100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.94431146130592E-13 |
Normal-vs-Age(41-60Yrs) |
5.10702591327572E-15 |
Normal-vs-Age(61-80Yrs) |
2.33146835171283E-15 |
Normal-vs-Age(81-100Yrs) |
2.66453525910038E-15 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.934800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.913400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.860000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.744800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.931800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.412400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.26101384679123E-12 |
Normal-vs-Grade 2 |
2.33146835171283E-15 |
Normal-vs-Grade 3 |
2.55351295663786E-15 |
Normal-vs-Grade 4 |
3.50830475781549E-14 |
Grade 1-vs-Grade 2 |
8.611900E-02 |
Grade 1-vs-Grade 3 |
8.220000E-02 |
Grade 1-vs-Grade 4 |
4.991800E-01 |
Grade 2-vs-Grade 3 |
8.666000E-01 |
Grade 2-vs-Grade 4 |
2.269800E-02 |
Grade 3-vs-Grade 4 |
2.644300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.33066907387547E-16 |
Normal-vs-ccB subtype |
5.44009282066327E-15 |
ccA subtype-vs-ccB subtype |
1.378960E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62814206561279E-12 |
Normal-vs-N1 |
1.27200472377353E-11 |
N0-vs-N1 |
3.437700E-02 |
|
|